These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 18301071)

  • 1. The role of protective HCP5 and HLA-C associated polymorphisms in the control of HIV-1 replication in a subset of elite suppressors.
    Han Y; Lai J; Barditch-Crovo P; Gallant JE; Williams TM; Siliciano RF; Blankson JN
    AIDS; 2008 Feb; 22(4):541-4. PubMed ID: 18301071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles.
    Catano G; Kulkarni H; He W; Marconi VC; Agan BK; Landrum M; Anderson S; Delmar J; Telles V; Song L; Castiblanco J; Clark RA; Dolan MJ; Ahuja SK
    PLoS One; 2008; 3(11):e3636. PubMed ID: 18982067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection.
    van Manen D; Kootstra NA; Boeser-Nunnink B; Handulle MA; van't Wout AB; Schuitemaker H
    AIDS; 2009 Jan; 23(1):19-28. PubMed ID: 19050382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.
    Salgado M; Swanson MD; Pohlmeyer CW; Buckheit RW; Wu J; Archin NM; Williams TM; Margolis DM; Siliciano RF; Garcia JV; Blankson JN
    J Virol; 2014 Mar; 88(6):3340-52. PubMed ID: 24390323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism in the HCP5 gene associated with HLA-B*5701 does not restrict HIV-1 in vitro.
    Yoon W; Ma BJ; Fellay J; Huang W; Xia SM; Zhang R; Shianna KV; Liao HX; Haynes BF; Goldstein DB;
    AIDS; 2010 Jan; 24(1):155-7. PubMed ID: 19935381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 control.
    van Manen D; Gras L; Boeser-Nunnink BD; van Sighem AI; Maurer I; Mangas Ruiz MM; Harskamp AM; Steingrover R; Prins JM; de Wolf F; van 't Wout AB; Schuitemaker H;
    AIDS; 2011 Nov; 25(18):2217-26. PubMed ID: 21860345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the Polymorphism
    Herráiz-Nicuesa L; Hernández-Flórez DC; Valor L; García-Consuegra S; Navarro-Valdivieso JP; Fernández-Cruz E; Rodríguez-Sainz C
    J Immunol Res; 2017; 2017():8689313. PubMed ID: 29445759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A whole-genome association study of major determinants for host control of HIV-1.
    Fellay J; Shianna KV; Ge D; Colombo S; Ledergerber B; Weale M; Zhang K; Gumbs C; Castagna A; Cossarizza A; Cozzi-Lepri A; De Luca A; Easterbrook P; Francioli P; Mallal S; Martinez-Picado J; Miro JM; Obel N; Smith JP; Wyniger J; Descombes P; Antonarakis SE; Letvin NL; McMichael AJ; Haynes BF; Telenti A; Goldstein DB
    Science; 2007 Aug; 317(5840):944-7. PubMed ID: 17641165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms.
    Moroni M; Ghezzi S; Baroli P; Heltai S; De Battista D; Pensieroso S; Cavarelli M; Dispinseri S; Vanni I; Pastori C; Zerbi P; Tosoni A; Vicenzi E; Nebuloni M; Wong K; Zhao H; McHugh S; Poli G; Lopalco L; Scarlatti G; Biassoni R; Mullins JI; Malnati MS; Alfano M
    J Transl Med; 2014 Dec; 12():335. PubMed ID: 25477316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential prevalence of the HLA-C -- 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals.
    Ballana E; Ruiz-de Andres A; Mothe B; Ramirez de Arellano E; Aguilar F; Badia R; Grau E; Clotet B; del Val M; Brander C; Esté JA
    Immunobiology; 2012 Sep; 217(9):889-94. PubMed ID: 22333575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence after imputation for a role of MICA variants in nonprogression and elite control of HIV type 1 infection.
    Le Clerc S; Delaneau O; Coulonges C; Spadoni JL; Labib T; Laville V; Ulveling D; Noirel J; Montes M; Schächter F; Caillat-Zucman S; Zagury JF
    J Infect Dis; 2014 Dec; 210(12):1946-50. PubMed ID: 24939907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701.
    Rodríguez-Nóvoa S; Cuenca L; Morello J; Córdoba M; Blanco F; Jiménez-Nácher I; Soriano V
    J Antimicrob Chemother; 2010 Aug; 65(8):1567-9. PubMed ID: 20534626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An additive effect of protective host genetic factors correlates with HIV nonprogression status.
    Salgado M; Simón A; Sanz-Minguela B; Rallón NI; López M; Vicario JL; Benito JM; Rodés B
    J Acquir Immune Defic Syndr; 2011 Apr; 56(4):300-5. PubMed ID: 21084992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low frequency of GB virus C viremia in a cohort of HIV-1-infected elite suppressors.
    Blankson JN; Klinzman D; Astemborski J; Thomas DL; Kirk GD; Stapleton JT
    AIDS; 2008 Nov; 22(17):2398-400. PubMed ID: 18981782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HLA-B/-C haplotype block contains major determinants for host control of HIV.
    Trachtenberg E; Bhattacharya T; Ladner M; Phair J; Erlich H; Wolinsky S
    Genes Immun; 2009 Dec; 10(8):673-7. PubMed ID: 19693088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective interleukin-28B genotype affects hepatitis C virus clearance, but does not contribute to HIV-1 control in a cohort of African-American elite controllers/suppressors.
    Salgado M; Kirk GD; Cox A; Rutebemberwa A; Higgins Y; Astemborski J; Thomas DL; Thio CL; Sulkowski MS; Blankson JN
    AIDS; 2011 Jan; 25(3):385-7. PubMed ID: 21099664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors.
    Blankson JN; Bailey JR; Thayil S; Yang HC; Lassen K; Lai J; Gandhi SK; Siliciano JD; Williams TM; Siliciano RF
    J Virol; 2007 Mar; 81(5):2508-18. PubMed ID: 17151109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
    Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
    J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HCP5 single-nucleotide polymorphism: a simple screening tool for prediction of hypersensitivity reaction to abacavir.
    Colombo S; Rauch A; Rotger M; Fellay J; Martinez R; Fux C; Thurnheer C; Günthard HF; Goldstein DB; Furrer H; Telenti A;
    J Infect Dis; 2008 Sep; 198(6):864-7. PubMed ID: 18684101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copy number variation and incomplete linkage disequilibrium interfere with the HCP5 genotyping assay for abacavir hypersensitivity.
    Melis R; Lewis T; Millson A; Lyon E; McMillin GA; Slev PR; Swensen J
    Genet Test Mol Biomarkers; 2012 Sep; 16(9):1111-4. PubMed ID: 22913531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.